Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Which Robo Advisor Is Best For Beginners compares onboarding ease, cost structures, and portfolio options to guide first-timers.
21,537 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
POET Technologies posted a quarterly miss as a Lumilens deal slows and litigation casts a shadow over growth prospect...
philly voters approve first city-run retirement program for workers without 401(k) plans, creating PhillySaves to aut...
Retirees should anchor planning on cash flow rather than asset size. Here is how the math stacks up in today's market...
Sara Holtz, chief marketing officer at Optimal Blue, outlines a leadership playbook that uses AI to sharpen decision-...
As Treasury yields rise in 2026, CDL’s $2.29 annual dividend delivers reliable monthly cash flow from a diversified m...
A surge in quantum-tech optimism helped lift IonQ shares even without direct news from the company. Here’s what happe...
An agreement settles customer claims against ftx’s former firm, auditor for $66 million, without admission of wrongdo...
The U.S. Department of Justice launches a nearly $1.8 billion fund to address claims of political targeting, promptin...